Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W C Alffenaar

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|April 14, 2010
Intravenous voriconazole after toxic oral administrationJ W C Alffenaar, S van Assen, J G R de Monchy, et al.
Seizure|April 6, 2007
Pyridoxine induces non-specific EEG alterations in infants with therapy resistant seizuresL K Teune, J H vd Hoeven, N M Maurits, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2011
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480J W C Alffenaar, T van der Laan, S Simons, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of TuberculosisN Alsaad, J A Dijkstra, O W Akkerman, et al.
The European Respiratory Journal|February 12, 2011
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experienceA D Pranger, R van Altena, R E Aarnoutse, et al.
International Journal of Antimicrobial Agents|August 1, 2015
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosisJ A Dijkstra, R van Altena, O W Akkerman, et al.
Talanta|March 11, 2014
Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MSD H Vu, R A Koster, M S Bolhuis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2023
TB therapeutic drug monitoring - analysis of opportunities in Romania and UkraineI Margineanu, T Butnaru, F Gafar, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisR van Altena, J A Dijkstra, M E van der Meer, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2020
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill PatientsJ M Boonstra, A G Märtson, I Sandaradura, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|April 14, 2010
Intravenous voriconazole after toxic oral administrationJ W C Alffenaar, S van Assen, J G R de Monchy, et al.
Seizure|April 6, 2007
Pyridoxine induces non-specific EEG alterations in infants with therapy resistant seizuresL K Teune, J H vd Hoeven, N M Maurits, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2011
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480J W C Alffenaar, T van der Laan, S Simons, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of TuberculosisN Alsaad, J A Dijkstra, O W Akkerman, et al.
The European Respiratory Journal|February 12, 2011
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experienceA D Pranger, R van Altena, R E Aarnoutse, et al.
International Journal of Antimicrobial Agents|August 1, 2015
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosisJ A Dijkstra, R van Altena, O W Akkerman, et al.
Talanta|March 11, 2014
Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MSD H Vu, R A Koster, M S Bolhuis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2023
TB therapeutic drug monitoring - analysis of opportunities in Romania and UkraineI Margineanu, T Butnaru, F Gafar, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisR van Altena, J A Dijkstra, M E van der Meer, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2020
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill PatientsJ M Boonstra, A G Märtson, I Sandaradura, et al.
Pageof 5